StockMarketWire.com - Amryt said its shares would be suspended from trading on the Euronext Growth Market from 4 Sept until on 20 Sept.

The company said it was informed that from 4 Sept, and until 8.00pm on 20 Sept 2019, certain central counterparties would not be supporting the clearing of trades in Amryt's shares.

Trading in the shares on the AIM market of the London Stock Exchange, however, would continue during this period and the company said it did not expect that trading on AIM would be affected as a result.


At 10:06am: [LON:AMYT] Amryt Pharma share price was 0p at 106.5p



Story provided by StockMarketWire.com